Global Filters




Tiers


Species


Attribution

Filter by Tier
Filter by Species
Filter by Attributions
like "mouse, Ap3m2, alcohol"

Search results are limited to 1000 results out of 1264. Try refining your search.

Returning 1000 results: Page 1 of 40


Tier Species Size Attr. GeneSet
Tier IV 10443 GS404760: Down regulated genes from ventral striatum from postmortem human brain tissue with Alcohol Use Disorder (AUD)
Tier III 17086 GS407944: Differentially expressed genes in opioid use disorder postmortem human brain_qvalue
Tier III 17086 GS407945: Differentially expressed genes in opioid use disorder postmortem human brain_log2FC
Tier III 18513 GS407948: Differentially expressed genes in humans nucleus accumbens associated with opioid use disorder_log2FC
Tier III 18278 GS407950: Differentially expressed genes in humans dorsolateral prefrontal cortex associated with opioid use disorder_log2FC
Tier IV 20956 GS409611: Differentially expressed genes in methadone treated human cortical organoids from combined iPSC lines vs untreated_qvalue
Tier IV 9415 GS404755: Down regulated genes from caudate nucleus (from dorsal striatum) from postmortem human brain tissue with Alcohol Use Disorder (AUD)
Tier IV 9868 GS404757: Down regulated genes from putamen (from dorsal striatum) from postmortem human brain tissue with Alcohol Use Disorder (AUD)
Tier IV 18653 GS407376: Dysregulation of NRSF/REST via EHMT1 is associated with psychiatric disorders and Kleefstra syndrome
Tier III 19111 GS407935: Differentially expressed genes in human kidney tumors associated with extended opioid exposure_logFC
Tier III 19863 GS407964: Differential gene expression in human postmortem tissue samples of the dorsolateral prefrontal cortex_logFC
Tier IV 9363 GS408182: Differential gene expression comparison between Carnegie Stages (CS) 15 and 22 during human embryo craniofacial development, log2FC
Tier IV 9363 GS408183: Differential gene expression comparison between Carnegie Stages (CS) 15 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 10391 GS408184: Differential gene expression comparison between Carnegie Stages (CS) 13 and 22 during human embryo craniofacial development, log2FC
Tier IV 10391 GS408185: Differential gene expression comparison between Carnegie Stages (CS) 13 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 9299 GS408186: Differential gene expression comparison between Carnegie Stages (CS) 17 and 22 during human embryo craniofacial development, log2FC
Tier IV 9299 GS408188: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 10134 GS408189: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, log2FC
Tier IV 10134 GS408190: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 21127 GS409617: Differentially expressed genes in methadone treated human cortical organoids from iPSC line B vs untreated_pvalue
Tier III 15761 GS409624: Differential gene expression within HepG2.2.15 cell line of fentanyl treated vs control human liver cells_pvalue
Tier IV 3151 GS3647: Meta-analysis of brain gene expression associated with voluntary consumption of ethanol in mice
Tier II 47 GS26262: Neocortex Gene expression correlates of Thermal Nociception Tail Withdrawal Test in Males BXD
Tier II 253 GS34093: Hippocampus Gene expression correlates of Open Field locomotion (activity beam breaks) 15-30 min post 2nd cocaine in Females BXD
Tier II 268 GS34123: Hippocampus Gene expression correlates of Open Field locomotion (cm) 15-30 min post 2nd cocaine in Females BXD